Estimaciones de analistas de Wall Street para Immunocore Holdings plc (IMCR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 9 |
| Mantener | 5 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 14 |
| Calificación media (1-5) | 0.64 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.16 | ||
| 2026-08-06 | $-0.02 | $-0.01 | -100.0% |
| 2026-05-06 | $0.25 | $-0.26 | +196.2% |
| 2026-02-25 | $-0.60 | $-0.28 | -114.3% |
| 2025-11-06 | $0.02 | $-0.30 | +105.2% |
| 2025-08-07 | $-0.20 | $-0.21 | +4.8% |
| 2025-05-07 | $0.10 | $-0.35 | +128.6% |
| 2025-02-26 | $-0.47 | $-0.31 | -51.6% |
Ratios de valoración
| Precio / Valor contable | 3.84 |
| EV / EBITDA | 110.19 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $16.5M | $14.4M | $23.7M | $25.7M | $30.1M | $27.0M | $144.2M | $197.4M | $248.0M | $297.6M |
| Coste de Ventas | 0 | 0 | 0 | $100.0M | $74.8M | 0 | $5.3M | $820634 | $5.5M | $6.2M |
| Beneficio Bruto | $16.5M | $14.4M | $23.7M | -$74.3M | -$44.7M | $27.0M | $138.9M | $196.6M | $242.4M | $291.4M |
| I+D | $46.0M | $61.2M | $83.6M | $100.0M | $74.8M | $74.3M | $84.3M | $129.4M | $177.4M | $204.5M |
| Generales y Administrativos | $3.7M | $22.0M | $34.2M | $44.2M | $45.7M | $82.2M | 0 | $114.3M | $121.2M | $120.6M |
| Gastos Operativos | $48.9M | $82.9M | $117.7M | $44.0M | $41.5M | $156.5M | $181.7M | $243.8M | $298.8M | $325.1M |
| Beneficio Operativo | -$32.5M | -$67.5M | -$93.5M | -$118.3M | -$86.2M | -$129.4M | -$42.8M | -$47.2M | -$56.3M | -$33.7M |
| EBITDA | -$29.8M | -$64.5M | -$86.7M | -$111.6M | -$82.4M | -$123.6M | -$38.4M | -$40.9M | -$38.5M | $387177 |
| Gastos por Intereses | 0 | 0 | $842000 | $3.8M | $3.1M | $5.6M | $5.4M | $4.1M | $18.8M | $12.2M |
| Beneficio Antes de Impuestos | -$31.2M | -$64.7M | -$88.2M | -$81.7M | -$87.4M | -$133.3M | -$33.8M | -$48.2M | -$42.3M | -$14.2M |
| Impuestos | $8.1M | $15.8M | -$16.5M | $22.3M | -$13.3M | $111191 | $9.6M | -$4.4M | -$1.5M | $12.2M |
| Beneficio Neto | -$23.1M | -$49.6M | -$71.6M | -$103.9M | -$74.1M | -$133.5M | -$43.5M | -$43.8M | -$40.8M | -$26.4M |
| BPA | $-9.45 | $-20.16 | $-2.62 | $-3.81 | $-2.33 | $-3.13 | $-0.95 | $-0.89 | $-1.02 | $-0.53 |
| BPA Diluido | $-9.45 | $-20.16 | $-2.62 | $-3.81 | $-2.33 | $-3.00 | $-0.95 | $-0.89 | $-1.02 | $-0.53 |
| Acciones en Circulación (Diluidas) | $2.4M | $2.5M | $27.3M | $27.3M | $31.8M | $43.9M | $45.7M | $48.9M | $50.0M | $50.3M |
Precio
| Precio | $31.59 |
| Capitalización | $1.6B |
| Bolsa | NASDAQ |
| País | GB |
Empresas relacionadas: ABCL · BHVN · CLDX · HRMY · JANX · MNKD · NUVB
Explorar sector: Healthcare · Biotechnology
Más secciones de IMCR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones